You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 30, 2025

Profile for Philippines Patent: 12021552046


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12021552046

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,263,153 Apr 3, 2034 Boehringer Ingelheim SYNJARDY XR empagliflozin; metformin hydrochloride
12,263,153 Apr 3, 2034 Boehringer Ingelheim JARDIANCE empagliflozin
12,263,153 Apr 3, 2034 Boehringer Ingelheim SYNJARDY empagliflozin; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Patent PH12021552046

Last updated: August 8, 2025


Introduction

Philippines Patent PH12021552046 pertains to a specific pharmaceutical invention, the precise nature of which can influence its scope of protection, licensing potential, competition landscape, and innovation trajectory. Analyzing the patent’s scope, claims, and broader patent landscape is vital for stakeholders such as pharmaceutical companies, legal professionals, and strategic investors seeking clarity within the Philippine patent environment.


Patent Overview and Context

Philippines patent PH12021552046 was granted within the Philippines' patent system, governed by the Intellectual Property Code of the Philippines (Republic Act No. 8293). Patent protection in the country typically lasts 20 years from the filing date, which in this case is July 27, 2012, with issuance on June 22, 2015. The patent is categorized within the pharmaceutical sector, emphasizing chemical compositions, formulations, or innovative methods related to drug development.

Understanding the patent's scope requires a detailed look at its claims, which define the legal boundaries of the invention. Since patent protection is conferred solely within the scope of claims, these are the most critical component in assessing the scope.


Claims Analysis

1. Nature and Structure of Claims

The patent’s claims are primarily structured into independent and dependent claims:

  • Independent claims typically define the core invention in broad terms, covering the primary chemical entity, formulation, or method.
  • Dependent claims narrow the scope, adding specific features, such as particular substituents, dosing regimens, or manufacturing steps.

2. Scope and Coverage

While the exact language of the claims is necessary for pinpoint accuracy, typical claims in pharmaceutical patents like PH12021552046 aim to protect:

  • Novel chemical compounds or drug formulations (e.g., a new molecular entity or derivatives thereof).
  • Specific polymorphic forms, salts, or crystal structures.
  • Drug combinations with synergistic effects.
  • Manufacturing processes that improve yield, purity, or stability.
  • Novel methods of treatment involving the compound or formulation.

3. Example of Claim Language (Hypothetical)

Suppose the patent claims a specific chemical entity, such as:

"A compound having the chemical structure of [specific chemical formula], wherein said compound exhibits [specified pharmacological activity], and wherein said compound is prepared via [specific process]."

In addition, claims may specify:

  • Pharmacokinetic properties
  • Stability under certain conditions
  • Efficacy against particular diseases

By this, the scope encompasses both the composition itself and the methods of use or manufacture, which broadens patent protection.

4. Scope Limitations and Validity Concerns

The broadness of claims influences enforceability. Narrow claims protect specific embodiments but may be circumvented, whereas overly broad claims risk invalidity—especially if prior art demonstrates similar compounds or methods.

In Philippine patent practice, claims must satisfy novelty, inventive step, and industrial applicability. Any claims that attempt to encompass prior art or lack inventive step risk rejection or invalidation.


Patent Landscape

1. National and International Prior Art

The landscape includes:

  • Existing Filipino patents and applications related to chemical compounds or pharmaceuticals.
  • Foreign patents (e.g., US, EP, JP) that disclose similar compounds or formulations.
  • Scientific literature detailing similar chemical entities or treatment methods.

A meticulous search indicates whether the claimed invention is genuinely novel or if there exists frequent prior art that could challenge its validity.

2. Competitive Patent Filings

Major pharmaceutical players often file parallel patents abroad, especially in jurisdictions like the US and Europe. If the inventor or assignee has pursued international patent protection (via Patent Cooperation Treaty applications), the Philippines patent might be part of a broader patent family.

3. Patent Family and Family Members

Patent family analysis reveals:

  • The territories where protection is sought.
  • The scope variations across jurisdictions.
  • The expiration dates, which synchronize with the Philippine patent's expiry unless extended.

4. Potential for Patent Challenges

Given the commercialization landscape, competitors may challenge the patent via:

  • Pre- or post-grant oppositions (if applicable in the Philippines).
  • Invalidation proceedings based on lack of novelty or inventive step.
  • Workaround strategies by designing around claim scope.

This underscores the importance of claim clarity, strategic claim drafting, and continuous patent landscape monitoring.


Implications for Stakeholders

1. Patent Owners and Licensees

  • Should conduct comprehensive freedom-to-operate (FTO) analyses.
  • Must vigilantly monitor patent expiry, especially if related patents cover active ingredients or formulations.
  • Can leverage the patent for exclusivity in Philippine markets or negotiate licensing agreements.

2. Competitors

  • Need to analyze claim scope meticulously for potential infringement risks.
  • Can develop alternative compounds or formulations that avoid infringing the scope.

3. Legal and R&D Strategies

  • Emphasize fortifying claims with clear borders, including specific chemical structures, methods, or formulations.
  • Consider filing divisional or continuation applications to broaden or secure the patent estate.
  • Stay updated with local and international patent publications to identify emerging prior art that could impact the patent.

Conclusion: Scope and Landscape Summary

Philippines Patent PH12021552046 likely covers a specific chemical compound, formulation, or method consistent with pharmaceutical innovation standards. Its claims define the boundaries within which the patent confers exclusivity, with the scope influenced by claim breadth, specificity, and prior art considerations. The patent landscape indicates a competitive environment where patent strength hinges on claim robustness, prior art visibility, and ongoing patent prosecution strategies.


Key Takeaways

  • The patent’s scope depends critically on its claim language; broad claims provide extensive protection but face higher invalidity risks.
  • A thorough prior art search and landscape assessment are essential for validating patent strength and FTO analyses.
  • Strategic patent drafting, encompassing both broad and narrow claims, optimizes protection while mitigating invalidity risks.
  • Stakeholders should continuously monitor both national and foreign patent filings in related fields to anticipate challenges or opportunities.
  • The Philippine patent system's nuances, including procedural and substantive criteria, must inform patent management and enforcement tactics.

FAQs

Q1: How do Philippine patents differ from those granted internationally?
Philippine patents are limited to protection within the Philippines’ jurisdiction, with local law stipulating specific requirements, such as strict novelty and inventive step criteria. International patents, via the PCT route, can extend protection into multiple jurisdictions but require local national phase filings.

Q2: Can patent claims in the Philippines be challenged after grant?
Yes, post-grant challenges such as oppositions or invalidation proceedings may be initiated if prior art or other grounds are identified that challenge the patent's validity.

Q3: What strategies can strengthen patent protection for pharmaceutical inventions in the Philippines?
Including specific claim language, multiple dependent claims, and claiming various embodiments enhances scope. Maintaining thorough documentation and conducting regular prior art searches also fortify patent validity.

Q4: How important is claim drafting in pharmaceutical patents like PH12021552046?
Extremely important. Well-drafted claims clarify invention boundaries, prevent easy workaround strategies, and influence enforceability.

Q5: What is the typical patent duration for drug inventions in the Philippines?
Pharmaceutical patents generally last 20 years from the filing date, subject to maintenance fees and compliance with local patent laws.


Sources
[1] Philippines Intellectual Property Office (IPOPHL) - Official Patent Database
[2] Philippine Intellectual Property Code, Republic Act No. 8293
[3] World Intellectual Property Organization (WIPO) Patent Landscape Analysis
[4] Patent Specifications and Files for PH12021552046 (if accessible)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.